Maxivision Eye Hospital has secured up to INR 1300 crores in private equity funding from Quadria Capital to enhance its growth and solidify its position in the Indian eye care sector.
Target Information
Maxivision Eye Hospital (“Maxivision”) has successfully secured private equity investment totaling up to INR 1300 crores from Quadria Capital, one of Asia’s foremost healthcare-focused private equity firms. This investment will significantly bolster Maxivision’s ability to enhance its service offerings and expand its operations.
Founded in 1996, Maxivision operates 42 eye care centers across five states in South and West India, with a strong presence in Andhra Pradesh and Telangana. The hospital provides a comprehensive array of eye care services including cataract surgery, LASIK, ReLEx Smile treatments, and care for retinal issues, glaucoma, oculoplasty, as well as specialized services for neonatal and pediatric patients.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The eye care industry in India has been experiencing exponential growth over the past decade, driven by increasing awareness of eye health, an aging population, and advancements in technology that make
Similar Deals
BC Investment (Bain Capital) → Emcure Pharmaceuticals Limited
2025
Somerset → Cyrix Healthcare
2024
ADV Partners → Dr. Agarwal’s Healthcare Limited
Kedaara Capital → Vijaya Diagnostic Centre Private Limited
WhiteOak Capital, Creador, Siguler Guff → La Renon Healthcare
Quadria Capital
invested in
Maxivision Eye Hospital
in
in a Other Private Equity deal
Disclosed details
Transaction Size: $156M